Short Interest in Click Holdings Limited (NASDAQ:CLIK) Expands By 490.1%

Click Holdings Limited (NASDAQ:CLIK) was the recipient of a significant growth in short interest in the month of January. As of January 15th, there was short interest totaling 3,446 shares, a growth of 490.1% from the December 31st total of 584 shares. Based on an average daily trading volume, of 9,700 shares, the short-interest ratio is presently 0.4 days. Approximately 0.3% of the company’s shares are sold short. Approximately 0.3% of the company’s shares are sold short. Based on an average daily trading volume, of 9,700 shares, the short-interest ratio is presently 0.4 days.

Click Stock Up 4.9%

CLIK opened at $4.93 on Wednesday. The company has a fifty day moving average price of $5.60 and a two-hundred day moving average price of $7.93. Click has a 52 week low of $4.32 and a 52 week high of $102.90.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Click in a research report on Monday, December 29th. One analyst has rated the stock with a Sell rating, According to MarketBeat, Click presently has an average rating of “Sell”.

Click Company Profile

Click Therapeutics, Inc (NASDAQ: CLIK) is a clinical-stage digital therapeutics company developing software-based treatments for neurological, psychiatric and chronic diseases. Its platform delivers prescription digital therapies via mobile and web applications, combining evidence-based cognitive behavioral interventions, digital monitoring tools and patient engagement techniques. Click’s approach is designed to complement or extend traditional pharmacological and behavioral treatments for conditions such as major depressive disorder, insomnia and tobacco use disorder.

Founded in 2014, Click has progressed multiple programs through randomized controlled trials and regulatory review.